Abstract:Background: SMA is a hereditary neuromuscular disease that causes progressive muscle weakness and atrophy. Several studies have shown that the burden of SMA is very high at many levels. Functional assessment tools currently used do not completely address the impact of the disease in patients' life. The objective of this qualitative study was to identify aspects of SMA that are relevant to patients and to design items useful for assessment purposes. Results: Five focus group sessions were run during an annual SMA families meeting in Madrid, Spain. Focus groups were composed by parents of SMA type I children, sitter children type II-III, parents of sitter children type II-III, adult patients, and parents of walker children. Two trained facilitators conducted the focus groups using a semi-structured guideline to cover previously agreed topics based on the input of a Scientific and Patient Advisory Committee. The guideline was adapted for the different groups. According to what was communicated by participants, SMA entails a high burden of disease for both patients and their parents. Burden was perceived in physical, psychological, and social areas. Patient's physical domain was the most relevant for participants, especially for parents of non-ambulant children, followed by limitations of motor scales to capture all changes, parents psychological burden, treatment expectations and patient's psychological burden. Ten domains were the main areas identified as impacted by the disease: mobility and independence, fatigue and fatigability, infections and hospital consultations, scoliosis and contractures, vulnerability, pain, feeding, time spent in care, breathing, and sleep and rest. Conclusions: This study confirms the necessity of evaluating other aspects of the disease that are not assessed in the functional motor scale. Measures of other aspects of the disease, such as pain, fatigue, feeding, should be also considered. A patient-reported outcomes instrument measuring such aspects in a valid and reliable way would be very useful. This study generated a list of new items relevant to be systematically measured in the assessment of the impact of SMA on the patients' everyday life.

EFFECTS OF TERAZOSIN ON GLYCEMIC CONTROL, CHOLESTEROL, AND MICROALBUMINURIA IN PATIENTS WITH NON‐INSULIN-DEPENDENT DIABETES MELLITUS AND HYPERTENSION

Mitochondrial Dysfunction in Spinal Muscular Atrophy

In Search of Spinal Muscular Atrophy Disease Modifiers

An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven‐institution analysis of 837 patients from the U.S. gastric cancer collaborative

Nutritional, Lipid Metabolic and Body Composition Features of Children with Spinal Muscular Atrophy

Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

Management of Spinal Muscular Atrophy in the Adult Population

Characterization of SMA type II skeletal muscle from treated patients shows OXPHOS deficiency and denervation

Advances and limitations for the treatment of spinal muscular atrophy

Prognostic Factors and Treatment‐Effect Modifiers in Spinal Muscular Atrophy

New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy

Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1

Diaphragm Fatigue in SMNΔ7 Mice and Its Molecular Determinants: An Underestimated Issue

Dominance of Plasmonic Resonant Energy Transfer over Direct Electron Transfer in Substantially Enhanced Water Oxidation Activity of BiVO4 by Shape-Controlled Au Nanoparticles.

Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy

Identification of the most relevant aspects of spinal muscular atrophy (SMA) with impact on the quality of life of SMA patients and their caregivers: the PROfuture project, a qualitative study

A continuous repetitive task to detect fatigability in spinal muscular atrophy

Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches

Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges